Laberge AM - Search Results

1

Improving recommendations for genomic medicine: building an evolutionary process from clinical practice advisory documents to guidelines.

Burke W, Clayton EW, Wolf SM, Berry SA, Evans BJ, Evans JP, Hall R, Korngiebel D, Laberge AM, LeRoy BS, McGuire AL. Burke W, et al. Among authors: laberge am. Genet Med. 2019 Nov;21(11):2431-2438. doi: 10.1038/s41436-019-0549-3. Epub 2019 Jun 4. Genet Med. 2019. PMID: 31160753 Free PMC article. Review.

2

Motivating factors for physician ordering of factor V Leiden genetic tests.

Hindorff LA, Burke W, Laberge AM, Rice KM, Lumley T, Leppig K, Rosendaal FR, Larson EB, Psaty BM. Hindorff LA, et al. Among authors: laberge am. Arch Intern Med. 2009 Jan 12;169(1):68-74. doi: 10.1001/archinternmed.2008.517. Arch Intern Med. 2009. PMID: 19139326 Free PMC article.

3

Long-term outcomes of the "Genetics in Primary Care" faculty development initiative.

Laberge AM, Fryer-Edwards K, Kyler P, Lloyd-Puryear MA, Burke W. Laberge AM, et al. Fam Med. 2009 Apr;41(4):266-70. Fam Med. 2009. PMID: 19343557

4

Use of Factor V Leiden genetic testing in practice and impact on management.

Laberge AM, Psaty BM, Hindorff LA, Burke W. Laberge AM, et al. Genet Med. 2009 Oct;11(10):750-6. doi: 10.1097/GIM.0b013e3181b3a697. Genet Med. 2009. PMID: 19668081 Free PMC article.

5

Clinical and public health implications of emerging genetic technologies.

Laberge AM, Burke W. Laberge AM, et al. Semin Nephrol. 2010 Mar;30(2):185-94. doi: 10.1016/j.semnephrol.2010.01.009. Semin Nephrol. 2010. PMID: 20347647 Free PMC article. Review.

6

Duty to warn at-risk family members of genetic disease.

Laberge AM, Burke W. Laberge AM, et al. Virtual Mentor. 2009 Sep 1;11(9):656-60. doi: 10.1001/virtualmentor.2009.11.9.ccas1-0909. Virtual Mentor. 2009. PMID: 23199459 Free article. No abstract available.

7

Testing minors for breast cancer.

Laberge AM, Burke W. Laberge AM, et al. Virtual Mentor. 2007 Jan 1;9(1):6-11. doi: 10.1001/virtualmentor.2007.9.1.ccas1-0701. Virtual Mentor. 2007. PMID: 23217662 Free article. No abstract available.

8

Recommending inclusion of HFE C282Y homozygotes in the ACMG actionable gene list: cop-out or stealth move toward population screening?

Laberge AM. Laberge AM. Genet Med. 2018 Apr;20(4):400-402. doi: 10.1038/gim.2017.161. Epub 2017 Oct 19. Genet Med. 2018. PMID: 29048418 Free article. No abstract available.

9

The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists.

Boycott K, Hartley T, Adam S, Bernier F, Chong K, Fernandez BA, Friedman JM, Geraghty MT, Hume S, Knoppers BM, Laberge AM, Majewski J, Mendoza-Londono R, Meyn MS, Michaud JL, Nelson TN, Richer J, Sadikovic B, Skidmore DL, Stockley T, Taylor S, van Karnebeek C, Zawati MH, Lauzon J, Armour CM; Canadian College of Medical Geneticists. Boycott K, et al. Among authors: laberge am. J Med Genet. 2015 Jul;52(7):431-7. doi: 10.1136/jmedgenet-2015-103144. Epub 2015 May 7. J Med Genet. 2015. PMID: 25951830 Free PMC article.

10

Points to consider for laboratories reporting results from diagnostic genomic sequencing.

Vears DF, Sénécal K, Clarke AJ, Jackson L, Laberge AM, Lovrecic L, Piton A, Van Gassen KLI, Yntema HG, Knoppers BM, Borry P. Vears DF, et al. Among authors: laberge am. Eur J Hum Genet. 2018 Jan;26(1):36-43. doi: 10.1038/s41431-017-0043-9. Epub 2017 Nov 28. Eur J Hum Genet. 2018. PMID: 29184171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page